
Grand Angels
Description
Grand Angels is a prominent angel investment group headquartered in Holland, Michigan, serving the West Michigan region and beyond. Established in 2004, the firm focuses on providing crucial early-stage capital to high-growth companies with disruptive technologies and strong management teams. Their investment philosophy extends beyond mere financial injection, emphasizing active mentorship, strategic guidance, and leveraging their extensive network to support portfolio companies' development and scaling efforts.
Since its inception, Grand Angels has made a significant impact on the regional entrepreneurial ecosystem. The group has deployed over $65 million in capital across more than 50 companies, demonstrating a consistent commitment to fostering innovation and economic growth. Their typical initial investment ranges from $250,000 to $1,000,000, positioning them as a key funding source for startups seeking seed or early Series A rounds. Grand Angels frequently participates in follow-on funding rounds, often increasing their total investment in a single company to several million dollars as it achieves milestones and demonstrates continued potential.
The firm's investment interests span a diverse array of high-potential sectors. They actively seek opportunities within life sciences, advanced manufacturing, and information technology, reflecting the region's economic strengths and emerging trends. Grand Angels prides itself on identifying companies that not only possess innovative products or services but also exhibit a clear path to market and a scalable business model. Their hands-on approach and deep industry expertise make them a valuable partner for entrepreneurs navigating the challenges of early-stage growth.
Investor Profile
Grand Angels has backed more than 24 startups, with 0 new investments in the last 12 months alone. The firm has led 5 rounds, about 21% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Series B rounds (top funding stages).
- Majority of deals are located in United States, South Africa.
- Strong thematic focus on Biotechnology, Health Care, Software.
- Typical check size: $250K – $1M.
Stage Focus
- Seed (29%)
- Series A (25%)
- Series B (17%)
- Series Unknown (13%)
- Debt Financing (8%)
- Convertible Note (4%)
- Angel (4%)
Country Focus
- United States (96%)
- South Africa (4%)
Industry Focus
- Biotechnology
- Health Care
- Software
- Life Science
- Medical Device
- Analytics
- Manufacturing
- Information Technology
- Medical
- Therapeutics
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.